CRO specializing in gene editing and delivery
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
270
NCT00755898
Urinary Excretion of Acetylamantadine by Cancer Patients
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2003
Completion: Jul 31, 2008
NCT02277938
Acetylamantadine Excretion by Cancer Patients
Phase: N/A
Start: Aug 31, 2013
Completion: Dec 31, 2021
Loading map...